Onco360® Celebrates Excellent Patient Care, Reflected by Impressive Net Promoter Score
LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) — This year, Onco360®, the nation’s leading independent specialty oncology pharmacy, celebrates excellent…
Pharmaceuticals, Biotechnology and Life Sciences
LOUISVILLE, Ky., March 14, 2024 (GLOBE NEWSWIRE) — This year, Onco360®, the nation’s leading independent specialty oncology pharmacy, celebrates excellent…
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),…
DALLAS, March 14, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage gene…
Rezdiffra Rezdiffra product image Rezdiffra becomes the first and only medication approved by the FDA for the treatment of NASH…
PURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical…
Interim data from initial dose escalation cohorts from Phase 1 trial of TERN-701 (allosteric BCR-ABL) for treatment of CML expected…
Initial proof of concept data from Phase 1a trial evaluating ELVN-001 in adults with chronic myeloid leukemia (CML) is expected…
Positive top-line data from Phase 2 dose exploration study of nomlabofusp, which was generally well-tolerated, with dose-dependent increases in tissue…
Cema-cel Pivotal ALPHA3 First Line (1L) Consolidation Trial in Large B-Cell Lymphoma (LBCL): Start-Up Activities Underway; Enrollment to Begin Mid-2024Cema-cel…
Significant progress made in preparing for a Phase 2b study evaluating Vaxart’s oral pill XBB COVID-19 vaccine against an approved…